Establishment and characterization of arsenic trioxide resistant KB/ATO cells

Arsenic trioxide (ATO) is used as a chemotherapeutic agent for the treatment of acute promyelocytic leukemia. However, increasing drug resistance is reducing its efficacy. Therefore, a better understanding of ATO resistance mechanism is required. In this study, we established an ATO-resistant human...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Acta Pharm Sin B
Autori principali: Zhang, Yun-Kai, Dai, Chunling, Yuan, Chun-gang, Wu, Hsiang-Chun, Xiao, Zhijie, Lei, Zi-Ning, Yang, Dong-Hua, Le, X. Chris, Fu, Liwu, Chen, Zhe-Sheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5595296/
https://ncbi.nlm.nih.gov/pubmed/28924550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2017.04.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi